ArticleJournal of asthma and allergy2019

Daily patient-reported health status assessment improvements with benralizumab for patients with severe, uncontrolled eosinophilic asthma.

Sean O'Quinn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.